Patent details

EP2793876 Title: PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
04/10/2023
Unitary Effect Status:
Unitary Effect Registered
Request Unitary Effect Accepted:
23/10/2023
Unitary Effect Date:
04/10/2023
Unitary Effect Registration Date:
23/10/2023
Request Unitary Effect Rejected:
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Unitary Effect request has been accepted, please see the UPP register at the EPO for up-to-date information
UPP register:
EP2793876
SPC Number:
Creation Date:

Basic Information

Publication number:
EP2793876
WO Application Number:
EP2012074915
Type:
European Patent Granted for NL
Status:
Unitary Effect Registered
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12801539.3
WO Publication Number:
WO2013092269
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
10/12/2012
Grant date:
04/10/2023
EP Publication Date:
29/10/2014
WO Publication Date:
27/06/2013
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
04/10/2023
EP B1 Publication Date:
04/10/2023
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
09/12/2032
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
04/10/2023
 
 

 

Name:
Kahrs, Bjoern Colin
Address:
Via Costa di Mezzo 54, 6614 Brissago, Switzerland (CH)

Inventor

Name:
Kahrs, Bjoern Colin
Address:
6614 Brissago, Switzerland (CH)

Priority

1

Priority Patent Number:
201213654632
Priority Date:
18/10/2012
Priority Country:
United States of America (US)

2

Priority Patent Number:
201261663761 P
Priority Date:
25/06/2012
Priority Country:
United States of America (US)

3

Priority Patent Number:
12004652
Priority Date:
21/06/2012
Priority Country:
European Patent Office (EPO) (EP)

4

Priority Patent Number:
11194292
Priority Date:
19/12/2011
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 31/225; A61K 31/4439; A61K 31/70; A61K 45/06; A61P 17/06; A61P 1/04; A61P 17/14; A61P 5/48; A61P 21/04; A61K 31/05; A61K 31/12; A61K 31/16; A61K 31/19; A61K 31/216; A61K 31/26; A61K 31/385; A61K 31/47;

Publication

Bulletin

1

Bulletin Heading:
UP1
Journal edition number:
47/23
Publication date:
22/11/2023
Description:
European patents with registered Unitary Effect

2

Bulletin Heading:
EP2
Journal edition number:
40/23
Publication date:
04/10/2023
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202347
Publication date:
22/11/2023
Description:
Unitary Effect Request Acceptance

2

Issue number:
202345
Publication date:
08/11/2023
Description:
Unitary Effect Request Receipt

3

Issue number:
202340
Publication date:
04/10/2023
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type